Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: A systematic review and meta-analysis of randomized trials

Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
American Journal of Clinical Nutrition (Impact Factor: 6.77). 03/2012; 95(3):740-51. DOI: 10.3945/ajcn.111.023457
Source: PubMed


There is substantial interest in chocolate and flavan-3-ols for the prevention of cardiovascular disease (CVD).
The objective was to systematically review the effects of chocolate, cocoa, and flavan-3-ols on major CVD risk factors.
We searched Medline, EMBASE, and Cochrane databases for randomized controlled trials (RCTs) of chocolate, cocoa, or flavan-3-ols. We contacted authors for additional data and conducted duplicate assessment of study inclusion, data extraction, validity, and random-effects meta-analyses.
We included 42 acute or short-term chronic (≤18 wk) RCTs that comprised 1297 participants. Insulin resistance (HOMA-IR: -0.67; 95% CI: -0.98, -0.36) was improved by chocolate or cocoa due to significant reductions in serum insulin. Flow-mediated dilatation (FMD) improved after chronic (1.34%; 95% CI: 1.00%, 1.68%) and acute (3.19%; 95% CI: 2.04%, 4.33%) intakes. Effects on HOMA-IR and FMD remained stable to sensitivity analyses. We observed reductions in diastolic blood pressure (BP; -1.60 mm Hg; 95% CI: -2.77, -0.43 mm Hg) and mean arterial pressure (-1.64 mm Hg; 95% CI: -3.27, -0.01 mm Hg) and marginally significant effects on LDL (-0.07 mmol/L; 95% CI: -0.13, 0.00 mmol/L) and HDL (0.03 mmol/L; 95% CI: 0.00, 0.06 mmol/L) cholesterol. Chocolate or cocoa improved FMD regardless of the dose consumed, whereas doses >50 mg epicatechin/d resulted in greater effects on systolic and diastolic BP. GRADE (Grading of Recommendations, Assessment, Development and Evaluation, a tool to assess quality of evidence and strength of recommendations) suggested low- to moderate-quality evidence of beneficial effects, with no suggestion of negative effects. The strength of evidence was lowered due to unclear reporting for allocation concealment, dropouts, missing data on outcomes, and heterogeneity in biomarker results in some studies.
We found consistent acute and chronic benefits of chocolate or cocoa on FMD and previously unreported promising effects on insulin and HOMA-IR. Larger, longer-duration, and independently funded trials are required to confirm the potential cardiovascular benefits of cocoa flavan-3-ols.

Download full-text


Available from: Jeffrey S Cohn, Jun 25, 2014
  • Source
    • "In this study, cocoa extract exhibited antioxidant activity, antihyperlipidemic and membrane stabilizing effect. The T. cacao extract may exert its protective effect by radical scavenging amongst other mechanisms; as intervention studies have suggested that cocoa has several beneficial effects on cardiovascular health, which includes the lowering of blood pressure, the improvement of vascular function and glucose metabolism, the reduction of platelet aggregation and adhesion (Sudano et al., 2012a) Cocoa and its flavanols increase nitric oxide (NO) bioavailability, activate nitric oxide synthase (NOS), and exert antioxidative, anti-inflammatory, and anti-platelet effects, which in turn improves vascular function, reduces blood pressure and therefore, explains the positive impact on clinical outcome proposed by epidemiological studies (Corti et al., 2009; Shrime et al., 2011; Hooper et al., 2012; Sudano et al., 2012b). More so, there is some evidence that flavanols and flavanol-rich foods including cocoa inhibit angiotensin-converting enzyme (ACE) activity in vitro (Actis-Goretta et al., 2003; Actis- Goretta et al., 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The effect of Theobroma cacao (cocoa) polyphenol on isoproterenol-induced myocardial infarction in Wistar rats was studied. Polyphenol was extracted from cocoa using hydroalcohol solvent. Twenty four rats divided into six groups of four rats each were used for the study. Groups 3, 4, 5 and 6 were pretreated with the extract (300, 500 and 700 mg/kg) and 100 mg/kg of atenolol respectively before administration with isoproterenol. Group 1 served as normal control and group 2 was administered with isoproterenol without treatment. The activities of marker enzymes, aspartate amino transferase (AST), alanine amino transferase (ALT) and lactate dehydrogenase (LDH) in both serum and heart tissue homogenate were assayed. Cocoa polyphenol ameliorated the leakage of marker enzymes from the heart into the serum and also restored the levels of these enzymes in the cardiomyocytes. Histological examination of heart tissues revealed marked ability of the extract to reduce the progression of infarct lesions.
    Journal of Applied Pharmaceutical Science 08/2015; 5(07):76-83. DOI:10.7324/JAPS.2015.50713 · 0.47 Impact Factor
    • "Flavanols, including (−)-epicatechin (EC), and their related oligomers, the procyanidins, are plant-derived compounds that occur in substantial amounts in certain food and beverages , including apples, berries, tea, wine, and cocoa-derived products. In recent years, various dietary intervention studies have demonstrated improvements in vascular function, blood pressure, and platelet reactivity following the intake of flavanol-and procyanidin-containing foods [1] [2]. However, it remains to be fully established whether or not currently "
    [Show abstract] [Hide abstract]
    ABSTRACT: An understanding of the pharmacokinetics of structurally related (-)-epicatechin metabolites (SREM) is a prerequisite for considering cocoa flavanols (CF) in the context of dietary recommendations. The objective of this study was to compare the absorption, metabolism, and excretion of SREM in healthy young and elderly Caucasian men. Intra-individual variability of SREM was assessed in 7 young subjects, after consuming 10.7 mg CF/kg body weight (BW) on two occasions separated by one week. The effect of age on flavanols ADME was assessed in 20 young (18-35y) and 20 elderly (65-80y) healthy male subjects receiving 5.3 and 10.7 mg total CF/kg BW or 1 g of acetaminophen as a control to compare differences in Phase II metabolism on 3 days separated by 1 week of wash-out. Blood and urine samples were collected for 24 h post consumption. The intra-individual variation, measured as CV(%) with respect to the area-under-the-curve of the concentration over time (AUC(0-6h) ) of SREM, was 16%, whilst the inter-individual variation in AUC(0-6h) , was 38%, comparable to acetaminophen (39%). The AUC(0-6h) and the 24 h excretion of total SREM was not significantly different between young and elderly subjects. At the high intake amount, the AUC(0-6h) of (-)-epicatechin-3'-β-D-glucuronide was greater in elderly subjects, whereas the AUC(0-6h) of 3'-O-methyl-(-)-epicatechin-5-sulfate and 3'-O-methyl-(-)-epicatechin-7-sulfate as well as the 24 h urinary excretion of γ-valerolactone (γ-VL) metabolites were lower in the elderly. Cocoa flavanols are absorbed, metabolized, and excreted in healthy young and elderly subjects with relatively small differences between the two groups. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Molecular Nutrition & Food Research 05/2015; 59(8). DOI:10.1002/mnfr.201500091 · 4.60 Impact Factor
    • "Whereas flavanols are found in cocoa, tea, apples, berries, and wine, inorganic nitrate is mainly found in beetroot and green leafy vegetables. Several well-controlled randomized human intervention studies have shown that cocoa flavanols have beneficial effects on blood pressure [4] [5], endothelial function [6] [7] [8] [9] [10], and other biomarkers of cardiovascular risk [11] [12]. These putative beneficial vascular effects, correlated with changes in plasma flavanol metabolites over time, were repeatable with pure (À )-epicatechin intake and inhibited by a nitric oxide synthase inhibitor, suggesting a cause-andeffect relationship between flavanols and vascular function improvements [10] [13]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dietary intervention studies have shown that flavanols and inorganic nitrate can improve vascular function, suggesting that these two bioactives may be responsible for beneficial health effects of diets rich in fruits and vegetables. To study interactions between cocoa flavanols (CF) and nitrate focusing on absorption, bioavailability, excretion, and efficacy to increase endothelial function. In a double-blind randomized, dose-response cross-over study, flow-mediated dilation (FMD) was measured in 15 healthy subjects before and at 1, 2, 3, and 4h following consumption of CF (1.4-10.9mg/kg body weight [bw]) or nitrate (0.1-10mg/kg bw). In order to study flavanol-nitrate interactions, an additional intervention trial was performed with nitrate and CF taken in sequence at low and high amounts. FMD was measured before (0h) and at 1h after ingestion of nitrate (3 or 8.5mg/kg bw) or water. Then subjects received a CF drink (2.7 or 10.9mg/kg bw) or a micro- and macronutrient matched CF-free drink. FMD was measured at 1, 2, and 4h thereafter. Blood and urine samples were collected and assessed for CF and NO-metabolites with HPLC and gas phase reductive chemiluminescence. Finally, intragastric formation of nitric oxide (NO) after CF and nitrate consumption was investigated. Both CF and nitrate induced a similar intake-dependent increase in FMD. Maximal values were achieved at 1h post ingestion and gradually decreased to reach baseline values at 4h. These effects were additive at low intake levels whereas CF did not further increase FMD after high nitrate intake. Nitrate did not affect flavanol absorption, bioavailability, or excretion but CF enhanced nitrate-related gastric NO formation and attenuated the increase in plasma nitrite after nitrate intake. Both flavanols and inorganic nitrate can improve endothelial function in healthy subjects at intake amounts that are achievable with a normal diet. Even low dietary intake of these bioactives may exert relevant effects on endothelial function when ingested together. Copyright © 2014 Elsevier Inc. All rights reserved.
    Free Radical Biology and Medicine 12/2014; 80. DOI:10.1016/j.freeradbiomed.2014.12.009 · 5.74 Impact Factor
Show more